Model Information:
Anaplastic oligodendroglioma, WHO grade III, with positive glial markers and a moderate proliferative index on immunohistochemistry.
Request a Custom Quote for XB5007 Xenograft ModelSummary:
| Category | Parameter | Model Detail (XB5007) |
| Identity | Model ID | XB5007 |
| Cancer Type | Brain Cancer | |
| Model Type | PDX (Patient-Derived Xenograft) | |
| Clinical Background | Patient Age | 51 |
| Patient Gender | Male | |
| Ethnicity | N/A | |
| Diagnosis | Anaplastic Oligodendroglioma | |
| Stage | WHO Grade 3 (Grade III) | |
| Sample Site | Brain (Frontal/Temporal Lobe) | |
| Genomics & Biomarkers | Primary Driver | IDH1 Mutation & 1p/19q Co-deletion / TERT Promoter |
| Cytogenetics | N/A | |
| WES (Whole Exome) | N/A | |
| RNA-Seq | N/A | |
| CNV Profile | N/A | |
| Mutational Load | N/A | |
| Characterization | Surface Markers | Olig2+, IDH1-R132H+, ATRX (Retained), Ki-67 (Moderate, ~15-20%) |
| Host Strain | NSG (NOD scid gamma) | |
| Inoculation Route | Orthotopic / Subcutaneous | |
| Growth Kinetic | N/A | |
| Pharmacology | SoC Response | N/A |
| Immune Profiling | N/A |
Growth Characteristics:
